New hope for myeloma patients Who've run out of options
Disease control
Recruiting now
This early-stage trial is testing whether combining three existing drugs—elotuzumab, CC-92480, and dexamethasone—is safe and effective for people with multiple myeloma that has returned or stopped responding to treatment. The study involves 27 patients whose cancer has progressed…
Phase: PHASE1 • Sponsor: Abdullah Khan • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC